BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

FermaVir Pharmaceuticals, Inc. 

420 Lexington Avenue

New York  New York  10170  U.S.A.
Phone: 212-375-2630 Fax:


SEARCH JOBS










 Company News
Shareholders Approve Inhibetex Therapeutics Inc. Acquisition of FermaVir Pharmaceuticals, Inc. (FMVR.OB) 9/20/2007 9:43:23 AM    More...
Preclinical Data on FermaVir Pharmaceuticals, Inc. (FMVR.OB)'s FV-100 Presented at the 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 9/19/2007 10:48:42 AM    More...
FermaVir Pharmaceuticals, Inc. (FMVR.OB) Announces Positive Data from Recent Preclinical Studies of FV-100 8/8/2007 1:38:31 PM    More...
The Day In Review: Entereg from GlaxoSmithKline (GSK) and Adolor Corporation (ADLR) Fails Test 4/10/2007 5:45:55 PM    More...
Inhibitex, Inc. (INHX) to Acquire FermaVir Pharmaceuticals, Inc. (FMVR.OB) for $19 Million in Stock 4/10/2007 8:50:40 AM    More...
FermaVir Pharmaceuticals, Inc. (FMVR.OB) CEO Featured in Exclusive Interview With WallSt.net 3/7/2007 11:09:47 AM    More...
RAB Capital Fund Raises Its Stake To 8.3% In FermaVir Pharmaceuticals, Inc. (FMVR.OB) 2/15/2007 12:22:17 PM    More...
FermaVir Pharmaceuticals, Inc. (FMVR.OB) Closes $1.27 Million Financing 1/16/2007 11:36:14 AM    More...
FermaVir Pharmaceuticals, Inc. (FMVR.OB)'s Founder And Board Member Professor Chris McGuigan Receives The Royal Society Of Chemistry's Award For Medicinal Chemistry 11/15/2006 11:19:00 AM    More...
FermaVir Pharmaceuticals, Inc. (FMVR.OB) Announces New Preclinical Data For FV-100, Its Clinical Candidate For Shingles; Recent Data Shows Excellent Penetration And Viral Inhibition By FV-100 In Cells 8/30/2006 11:05:17 AM    More...
12